Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective-Reference-Cited by-同舟云学术

Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective

Published:2014-12-11 Issue:1 Volume:56 Page:70-75
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Herrmann Ken,Czernin Johannes,Wolin Edward M.,Gupta Pawan,Barrio Martin,Gutierrez Antonio,Schiepers Christiaan,Mosessian Sherly,Phelps Michael E.,Allen-Auerbach Martin S.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference19 articles.

1. One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

2. Outcome of surgery for pancreatic neuroendocrine neoplasms;Fischer;Br J Surg.,2014

3. Sharma P Arora S Dhull VS . Evaluation of Ga-DOTANOC PET/CT imaging in a large exclusive population of pancreatic neuroendocrine tumors. Abdom Imaging. August 19, 2014 [Epub ahead of print].

4. Malignant pancreatic neuroendocrine tumour: Lymph node ratio and Ki67 are predictors of recurrence after curative resections

5. Elevated Plasma Chromogranin A Is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumors

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual Somatostatin Receptor/¹⁸F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors;Journal of Nuclear Medicine;2024-09-12

2. Visual and whole-body quantitative analyses of 68 Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with 177Lu-DOTATATE;Annals of Nuclear Medicine;2024-01-22

3. Gastrinoma;Neuroendocrine Tumours;2024

4. Prognostic Implications of PET-Derived Tumor Volume and Uptake in Patients with Neuroendocrine Tumors;Cancers;2023-07-12

5. Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms;Cancers;2023-07-04